IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)          Journal is Currently Not Indexed in Scopus as on february 2021 list provided by scopus

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Evaluation of streptokinase efficacy on the elimination of thrombosed tunneled-cuffed central venous catheter obstruction in hemodialysis patients

Author: HOSSEIN HEMMATI, MOHAMMAD TAGHI ASHOOBI, REIHANE EINOLLAHZADE, CYRUS EMIR ALAVI, MOHAYA FARZIN, ZAKIYEH JAFARYPARVAR, GHAZALEH HEMMATI
Abstract: Purpose: End-Stage Renal Disease (ESRD) is a severe form of chronic kidney disease (CKD). Hemodialysis has increased the life expectancy in patients with renal failure. The most common complication of vascular access is thrombosis in lines. Medical interventions such as anti-thrombolytic drugs can be more effective and affordable. In this study, we aimed to evaluate streptokinase efficacy on the success rate and secondary patency rate of thrombosed hemodialysis catheters. Methods: In this prosepective study, 34 dialysis patients with thrombosed permicaths who entered to Razi hospital, were examined. The study population included the hospital during one year and three months. The cases received streptokinase, three times according to protocol. Each of the successful cases had been controlled after three months. After collection, the data were analyzed by SPSS version 21. Results: The frequency of males and females was too close. Findings showed that the Streptokinase was effective in 80 % of patients. And this effect continued for 22.1±18.2 months on average, and more than 70 % of patients’ permcaths can be used after 3 months. More than 90% of patients didn?t report any allergic reactions, and the allergic reactions have been limited to fever, nausea and back pain. Conclusion: The study showed although the replacement of occluded dialysis catheters is expensive and invasive, using streptokinase is effective and affordable, and is more secure than invasive methods.
Keyword: Central Venous catheter, Thrombosis, Kidney Failure, Hemodialysis
DOI: https://doi.org/10.31838/ijpr/2020.12.04.072
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free